A prospective, randomized, controlled trial comparing highly purified hMG with recombinant FSH in women undergoing ICSI: ovarian response and clinical outcomes

By Kilani Z.  

Human Reproduction, Vol. 18, Iss. 6, 2003-06 ,pp. : 1194-1199

Oxford University Press

Access to resources Recommend Favorite

Outcome of in vitro fertilization following stimulation with highly purified hMG or recombinant FSH in downregulated women of advanced reproductive age: a prospective, randomized and controlled trial

By Ye Hong   Huang Guoning   Pei Li   Zeng Pinghong   Luo Xiu  

Gynecological Endocrinology, Vol. 28, Iss. 7, 2012-07 ,pp. : 540-544

Informa Healthcare

Access to resources Recommend Favorite

Efficacy of recombinant versus human derived follicle stimulating hormone on the oocyte and embryo quality in IVF-ICSI cycles: Randomised, controlled, multi-centre trial

By Abate Antonino   Nazzaro Alfredo   Salerno Annalisa   Marzano Francesca   Pavone Cossut Maria   Perino Maria  

Gynecological Endocrinology, Vol. 25, Iss. 8, 2009-08 ,pp. : 479-484

Informa Healthcare

Access to resources Recommend Favorite

Recombinant human LH supplementation versus recombinant human FSH (rFSH) step-up protocol during controlled ovarian stimulation in normogonadotrophic women with initial inadequate ovarian response to rFSH. A multicentre, prospective, randomized controlled trial

By De Placido G.  

Human Reproduction, Vol. 20, Iss. 2, 2005-02 ,pp. : 390-396

Oxford University Press

Access to resources Recommend Favorite

Clinical outcome following stimulation with highly purified hMG or recombinant FSH in patients undergoing IVF: a randomized assessor-blind controlled trial

By Andersen Anders Nyboe   Devroey Paul   for the MERIT Group  

Human Reproduction, Vol. 21, Iss. 12, 2006-12 ,pp. : 3217-3227

Oxford University Press

Access to resources Recommend Favorite